Cargando…

Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care

BACKGROUND: The COPD Diagnostic Questionnaire (CDQ) was developed to identify people who would benefit from spirometry testing to confirm Chronic Obstructive Pulmonary Disease (COPD). The aim of this study was to determine the usefulness of a cut-off score of 16.5 on the CDQ in identifying those at...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagano, Lisa, McKeough, Zoe, Wootton, Sally, Zwar, Nicholas, Dennis, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010070/
https://www.ncbi.nlm.nih.gov/pubmed/35421929
http://dx.doi.org/10.1186/s12875-022-01685-z
_version_ 1784687404393693184
author Pagano, Lisa
McKeough, Zoe
Wootton, Sally
Zwar, Nicholas
Dennis, Sarah
author_facet Pagano, Lisa
McKeough, Zoe
Wootton, Sally
Zwar, Nicholas
Dennis, Sarah
author_sort Pagano, Lisa
collection PubMed
description BACKGROUND: The COPD Diagnostic Questionnaire (CDQ) was developed to identify people who would benefit from spirometry testing to confirm Chronic Obstructive Pulmonary Disease (COPD). The aim of this study was to determine the usefulness of a cut-off score of 16.5 on the CDQ in identifying those at increased risk of obstruction, in a mixed population of people ‘at risk’ of COPD and those with an ‘existing’ COPD diagnosis. METHODS: People ‘at risk’ of COPD (aged > 40 years, current/ex-smoker) and those with ‘existing’ COPD were identified from four general practices and invited to participate. Participants completed the CDQ and those with a CDQ score ≥ 16.5 were categorised as having intermediate to increased likelihood of airflow obstruction. Pre and post-bronchodilator spirometry determined the presence of airway obstruction (FEV(1)/FVC ratio < 0.7). Sensitivity, specificity and accuracy of the CDQ was determined compared to spirometry as the gold standard. RESULTS: One hundred forty-one participants attended an initial assessment (‘at risk’ = 111 (79%), ‘existing’ COPD = 30 (21%)). A cut-off score of 16.5 corresponded to a sensitivity of 81%, specificity of 36% and accuracy of 50%, in the entire mixed population. The area under the ROC curve was 0.59 ± 0.50 indicating low diagnostic accuracy of the CDQ. Similar results were found in the ‘existing’ COPD group alone. CONCLUSION: Whilst a cut-off score of 16.5 on the CDQ may result in a large number of false positives, clinicians may still wish to use the CDQ to refine who receives spirometry due to its high sensitivity. TRIAL REGISTRATION: ANZCTR, ACTRN12619001127190. Registered 12 August 2019 – Retrospectively registered, http://www.ANZCTR.org.au/ACTRN12619001127190.aspx
format Online
Article
Text
id pubmed-9010070
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90100702022-04-15 Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care Pagano, Lisa McKeough, Zoe Wootton, Sally Zwar, Nicholas Dennis, Sarah BMC Prim Care Research BACKGROUND: The COPD Diagnostic Questionnaire (CDQ) was developed to identify people who would benefit from spirometry testing to confirm Chronic Obstructive Pulmonary Disease (COPD). The aim of this study was to determine the usefulness of a cut-off score of 16.5 on the CDQ in identifying those at increased risk of obstruction, in a mixed population of people ‘at risk’ of COPD and those with an ‘existing’ COPD diagnosis. METHODS: People ‘at risk’ of COPD (aged > 40 years, current/ex-smoker) and those with ‘existing’ COPD were identified from four general practices and invited to participate. Participants completed the CDQ and those with a CDQ score ≥ 16.5 were categorised as having intermediate to increased likelihood of airflow obstruction. Pre and post-bronchodilator spirometry determined the presence of airway obstruction (FEV(1)/FVC ratio < 0.7). Sensitivity, specificity and accuracy of the CDQ was determined compared to spirometry as the gold standard. RESULTS: One hundred forty-one participants attended an initial assessment (‘at risk’ = 111 (79%), ‘existing’ COPD = 30 (21%)). A cut-off score of 16.5 corresponded to a sensitivity of 81%, specificity of 36% and accuracy of 50%, in the entire mixed population. The area under the ROC curve was 0.59 ± 0.50 indicating low diagnostic accuracy of the CDQ. Similar results were found in the ‘existing’ COPD group alone. CONCLUSION: Whilst a cut-off score of 16.5 on the CDQ may result in a large number of false positives, clinicians may still wish to use the CDQ to refine who receives spirometry due to its high sensitivity. TRIAL REGISTRATION: ANZCTR, ACTRN12619001127190. Registered 12 August 2019 – Retrospectively registered, http://www.ANZCTR.org.au/ACTRN12619001127190.aspx BioMed Central 2022-04-14 /pmc/articles/PMC9010070/ /pubmed/35421929 http://dx.doi.org/10.1186/s12875-022-01685-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pagano, Lisa
McKeough, Zoe
Wootton, Sally
Zwar, Nicholas
Dennis, Sarah
Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care
title Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care
title_full Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care
title_fullStr Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care
title_full_unstemmed Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care
title_short Accuracy of the COPD diagnostic questionnaire as a screening tool in primary care
title_sort accuracy of the copd diagnostic questionnaire as a screening tool in primary care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010070/
https://www.ncbi.nlm.nih.gov/pubmed/35421929
http://dx.doi.org/10.1186/s12875-022-01685-z
work_keys_str_mv AT paganolisa accuracyofthecopddiagnosticquestionnaireasascreeningtoolinprimarycare
AT mckeoughzoe accuracyofthecopddiagnosticquestionnaireasascreeningtoolinprimarycare
AT woottonsally accuracyofthecopddiagnosticquestionnaireasascreeningtoolinprimarycare
AT zwarnicholas accuracyofthecopddiagnosticquestionnaireasascreeningtoolinprimarycare
AT dennissarah accuracyofthecopddiagnosticquestionnaireasascreeningtoolinprimarycare